Kura Oncology, Inc.
KURA
$5.95
$0.223.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -57.43M | -19.22M | -54.40M | -50.84M | -49.53M |
| Total Depreciation and Amortization | 241.00K | 204.00K | 208.00K | 202.00K | 234.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.31M | 5.89M | 5.02M | 5.01M | 5.36M |
| Change in Net Operating Assets | -20.05M | 282.26M | 5.74M | 3.10M | -4.92M |
| Cash from Operations | -71.93M | 269.13M | -43.44M | -42.53M | -48.84M |
| Capital Expenditure | -292.00K | -372.00K | 0.00 | -16.00K | -84.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -101.12M | -94.58M | 45.54M | 43.18M | -95.25M |
| Cash from Investing | -101.41M | -94.96M | 45.54M | 43.17M | -95.34M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 143.00K | 806.00K | 2.20M | 3.04M | 148.37M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 143.00K | 806.00K | 2.20M | 3.04M | 148.37M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -173.19M | 174.98M | 4.30M | 3.68M | 4.19M |